Evidence map›Paper›PMID 23720660›Full record

ArticleFrontiers in immunology2013

Epigenetic Activation and Silencing of the Gene that Encodes IFN-γ.

Thomas M Aune, Patrick L Collins, Sarah P Collier, Melodie A Henderson, Shaojing Chang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. CRIF1 deficiency induces FOXP3Science advances · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. IFN-γ, should not be ignored in SLE.Frontiers in immunology · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Exposure of Human CD8Frontiers in immunology · 2018
    Article
  17. The methylation state ofJournal of thoracic disease · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Thomas M AuneDepartment of Medicine, Vanderbilt University School of Medicine Nashville, TN, USA ; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine Nashville, TN, USA.
Patrick L Collins
Sarah P Collier
Melodie A Henderson
Shaojing Chang
Vanderbilt University · US

Funding

IFN GAMMA GENE REGULATION IN T CELLS AND NK CELLSR01AI044924 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI AUNE, THOMAS M. · 2000 to 2019
$5.8M
NIAID NIH HHS R01 AI044924
6 · The paper itself

Abstract

Transcriptional activation and repression of genes that are developmentally regulated or exhibit cell-type specific expression patterns is largely achieved by modifying the chromatin template at a gene locus. Complex formation of stable epigenetic histone marks, loss or gain of DNA methylation, alterations in chromosome conformation, and specific utilization of both proximal and distal transcriptional enhancers and repressors all contribute to this process. In addition, long non-coding RNAs are a new species of regulatory RNAs that either positively or negatively regulate transcription of target gene loci. IFN-γ is a pro-inflammatory cytokine with critical functions in both innate and adaptive arms of the immune system. This review focuses on our current understanding of how the chromatin template is modified at the IFNG locus during developmental processes leading to its transcriptional activation and silencing.

Indexed as

CpG methylationepigeneticsinterferon-gammalong non-coding RNAnatural killer cellsnatural killer T cellsT helper cells

Identifiers

PMID23720660
PMCPMC3655339
OpenAlexW2096066928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.